Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc
June 18, 2015 – New York, NY – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the sole placement agent Laidlaw & Company (UK) in a registered direct offering of Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted immunotherapeutics for the treatment of advanced cancers. The offering consisted of 1,923,078 shares of the Company’s common stock issued at a purchase price of $2.60 per share for aggregate gross proceeds ofapproximately $5,000,000.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Richard A. Friedman and Stephen A. Cohen
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Partner Benjamin Tan Joins China Internet Nationwide Financial Services, Inc. in Ringing the Closing Bell at Nasdaq MarketSite - August 17, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc. - August 16, 2017
- Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering - August 16, 2017